SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-020199
Filing Date
2024-04-17
Accepted
2024-04-17 08:00:38
Documents
4
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20018840x1_def14a.htm DEF 14A 749337
2 ny20018840x1_pc01.jpg GRAPHIC 587708
3 ny20018840x1_pc02.jpg GRAPHIC 615539
4 sig_timran.jpg GRAPHIC 25012
  Complete submission text file 0001140361-24-020199.txt   2441117
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40672 | Film No.: 24849388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)